Total Payments
$2,011
2020 Payments
$27.91
Companies
14
Transactions
202
Medicare Patients
1,009
Medicare Billing
$111,684
Payment Breakdown by Category
Food & Beverage$2,011 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,011 | 202 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $289.23 | 40 | $0 (2018) |
| Novo Nordisk Inc | $279.59 | 19 | $0 (2020) |
| PFIZER INC. | $261.11 | 29 | $0 (2018) |
| Amgen Inc. | $251.36 | 22 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $220.72 | 21 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $163.53 | 39 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $144.23 | 6 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $95.00 | 6 | $0 (2018) |
| Lilly USA, LLC | $82.11 | 5 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $81.73 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $27.91 | 2 | Novo Nordisk Inc ($27.91) |
| 2019 | $244.83 | 18 | Novo Nordisk Inc ($143.44) |
| 2018 | $525.88 | 53 | PFIZER INC. ($113.36) |
| 2017 | $1,212 | 129 | Merck Sharp & Dohme Corporation ($177.68) |
All Payment Transactions
202 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/11/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS, Tresiba | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: Diabetes | ||||||
| 01/07/2020 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Diabetes | ||||||
| 11/13/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Diabetes | ||||||
| 11/13/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Diabetes | ||||||
| 10/28/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.86 | General |
| Category: Bone Health | ||||||
| 10/11/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: DIABETES | ||||||
| 10/08/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $11.37 | General |
| Category: Bone Health | ||||||
| 09/16/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: Diabetes | ||||||
| 08/22/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: Diabetes | ||||||
| 08/09/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Diabetes | ||||||
| 08/08/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: RESPIRATORY | ||||||
| 07/26/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $10.87 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/22/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Diabetes | ||||||
| 06/21/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Diabetes | ||||||
| 06/19/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: Diabetes | ||||||
| 05/20/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $10.83 | General |
| Category: Bone Health | ||||||
| 04/16/2019 | Novo Nordisk Inc | Tresiba (Drug), Victoza, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Diabetes | ||||||
| 03/11/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/17/2019 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, SHINGRIX | Food and Beverage | In-kind items and services | $19.35 | General |
| Category: VACCINES | ||||||
| 01/04/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Diabetes | ||||||
| 12/19/2018 | Merck Sharp & Dohme Corporation | ROTATEQ (Biological), PNEUMOVAX 23, GARDASIL9 | Food and Beverage | In-kind items and services | $4.09 | General |
| Category: VACCINE | ||||||
| 12/18/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $10.65 | General |
| Category: DIABETES | ||||||
| 11/29/2018 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Neuroscience | ||||||
| 11/15/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: Neuroscience | ||||||
| 11/12/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 4 | 62 | 75 | $7,738 | $5,083 |
| 2021 | 7 | 452 | 648 | $65,791 | $49,660 |
| 2020 | 6 | 495 | 677 | $73,237 | $56,942 |
Total Patients
1,009
Total Services
1,400
Medicare Billing
$111,684
Procedure Codes
17
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $2,497 | $1,492 | 59.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 32 | $2,214 | $1,447 | 65.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 16 | $1,592 | $1,191 | 74.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 14 | 14 | $1,436 | $952.36 | 66.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 117 | 246 | $24,630 | $19,091 | 77.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 76 | 79 | $15,342 | $11,283 | 73.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 95 | 102 | $10,405 | $7,711 | 74.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 90 | 144 | $9,977 | $7,520 | 75.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 38 | 40 | $2,801 | $2,128 | 76.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 24 | 25 | $1,814 | $1,337 | 73.7% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 12 | 12 | $821.52 | $589.00 | 71.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 132 | 243 | $25,676 | $19,722 | 76.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 88 | 93 | $18,552 | $14,675 | 79.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 110 | 116 | $12,508 | $9,654 | 77.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 103 | 162 | $11,579 | $9,273 | 80.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 43 | 44 | $3,274 | $2,581 | 78.8% |
| 99217 | Hospital observation care on day of discharge | Facility | 2020 | 19 | 19 | $1,648 | $1,037 | 63.0% |
About Dr. Philip Meyer, DO
Dr. Philip Meyer, DO is a Internal Medicine healthcare provider based in Pierre, South Dakota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1972595981.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Meyer, DO has received a total of $2,011 in payments from pharmaceutical and medical device companies, with $27.91 received in 2020. These payments were reported across 202 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,011).
As a Medicare-enrolled provider, Meyer has provided services to 1,009 Medicare beneficiaries, totaling 1,400 services with total Medicare billing of $111,684. Data is available for 3 years (2020–2022), covering 17 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Pierre, SD
- Active Since 08/16/2005
- Last Updated 03/19/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1972595981
Products in Payments
- JANUVIA (Drug) $173.55
- Prolia (Biological) $144.69
- Ozempic (Drug) $125.16
- JARDIANCE (Drug) $122.06
- VIAGRA (Drug) $108.91
- INVOKANA (Drug) $96.62
- CHANTIX (Drug) $96.43
- Victoza (Drug) $96.15
- ENTRESTO (Drug) $95.00
- SYMBICORT (Drug) $88.76
- STIOLTO (Drug) $75.67
- XARELTO (Drug) $66.91
- ASMANEX (Drug) $61.46
- HUMALOG (Drug) $60.63
- Tresiba (Drug) $58.28
- FARXIGA (Drug) $55.47
- Prolastin-C (Biological) $52.49
- Repatha (Biological) $50.56
- TOUJEO (Drug) $50.25
- ZOSTAVAX (Biological) $37.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.